AI assistant
Outset Medical, Inc. — Director's Dealing 2021
Mar 18, 2021
33476_dirs_2021-03-17_5aa37374-3216-4d8a-8a91-42e9faa59ba3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2021-03-15
Reporting Person: Vazquez Martin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-15 | Common Stock | A | 8255 | — | Acquired | 9255 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-15 | Stock Option (Right to Buy) | $25.89 | A | 16416 | Acquired | 2031-03-14 | Common Stock (16416) | Direct |
Footnotes
F1: Represents restricted stock units ("RSU") granted to the reporting person on March 15, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on March 15, 2022, then quarterly over three years on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.
F2: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.